The Antitrust Review of the Americas 2018

United States: Pharmaceutical Antitrust

Introduction The past year has continued to see an increase in US case law developments in the area of pharmaceutical antitrust. This article focuses on the three types of pharmaceutical antitrust cases that have been most active:

Interested in becoming a GCR author? Please contact our Insight Manager.

Get in touch